Literature DB >> 11861974

A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.

Vickie S Wilson1, Kathy Bobseine, Christy R Lambright, L E Gray.   

Abstract

The U.S. Environmental Protection Agency has proposed that in vitro assays for estrogen receptor (ER)- and androgen receptor (AR)-mediated actions be included in a Tier-I screening battery to detect hormonally active chemicals. Herein we describe the development of a novel stable cell line, MDA-kb2, for screening of androgen agonist and antagonists and to characterize its specificity and sensitivity to endocrine-disrupting chemicals. The breast cancer cell line, MDA-MB-453, was stably transformed with the MMTV.luciferase.neo reporter gene construct. Since both GR and AR are present in the MDA-MB-453 cells, and both receptors can act through the MMTV promoter, compounds that act through either AR or GR activate the MMTV luciferase reporter. As expected, AR agonists such as dihydrotestosterone (DHT), and GR agonists such as dexamethasone (DEX), corticosterone, and aldosterone induce luciferase expression at appropriate concentrations. DHT consistently produced 3-9-fold induction at concentrations from 0.1 to 10 nM. At 1 to 1000 nM, DEX induced luciferase activity 1.3-19.5-fold. To distinguish AR- from GR-mediated ligands, chemicals were assayed concurrently with the antiandrogen, hydroxyflutamide (OHF), which blocks AR- but not GR-mediated responses. In addition, known AR antagonists, including hydroxyflutamide, vinclozolin, vinclozolin metabolites M1 and M2, p,p'-DDE, and linuron inhibited DHT-induced luciferase gene expression at appropriate concentrations in this system. We have found that these cells are relatively easy to culture and maintain. Responsiveness was monitored over time and was stable for more than 80 passages. Some advantages of this assay are that it is relatively rapid (2 days), eliminates the need for transfection, can be conducted in a 96-well plate format, and produces consistent reproducible results. In summary, we have developed a cell line that can be used to screen chemicals, not just for AR- but for GR-mediated activities as well.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861974     DOI: 10.1093/toxsci/66.1.69

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  66 in total

1.  Proposal to optimize ecotoxicological evaluation of wastewater treated by conventional biological and ozonation processes.

Authors:  Adriana Wigh; Alain Devaux; Vanessa Brosselin; Adriana Gonzalez-Ospina; Bruno Domenjoud; Selim Aït-Aïssa; Nicolas Creusot; Antoine Gosset; Christine Bazin; Sylvie Bony
Journal:  Environ Sci Pollut Res Int       Date:  2015-09-24       Impact factor: 4.223

2.  Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.

Authors:  Jason Gavenonis; Nicholas E Jonas; Joshua A Kritzer
Journal:  Bioorg Med Chem       Date:  2014-06-14       Impact factor: 3.641

3.  Polyester monomers lack ability to bind and activate both androgenic and estrogenic receptors as determined by in vitro and in silico methods.

Authors:  Thomas G Osimitz; William J Welsh; Ni Ai; Colleen Toole
Journal:  Food Chem Toxicol       Date:  2014-10-28       Impact factor: 6.023

4.  Predicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing.

Authors:  Raja S Settivari; Nicholas Ball; Lynea Murphy; Reza Rasoulpour; Darrell R Boverhof; Edward W Carney
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

5.  An integrated approach for identifying priority contaminant in the Great Lakes Basin - Investigations in the Lower Green Bay/Fox River and Milwaukee Estuary areas of concern.

Authors:  Shibin Li; Daniel L Villeneuve; Jason P Berninger; Brett R Blackwell; Jenna E Cavallin; Megan N Hughes; Kathleen M Jensen; Zachary Jorgenson; Michael D Kahl; Anthony L Schroeder; Kyle E Stevens; Linnea M Thomas; Matthew A Weberg; Gerald T Ankley
Journal:  Sci Total Environ       Date:  2016-11-18       Impact factor: 7.963

6.  First characterization of the endocrine-disrupting potential of indoor gaseous and particulate contamination: comparison with urban outdoor air (France).

Authors:  Lucie Oziol; Fabrice Alliot; Jérémie Botton; Maya Bimbot; Viviane Huteau; Yves Levi; Marc Chevreuil
Journal:  Environ Sci Pollut Res Int       Date:  2016-11-18       Impact factor: 4.223

Review 7.  Cell-based assays for screening androgen receptor ligands.

Authors:  Carmela Campana; Vincenzo Pezzi; William E Rainey
Journal:  Semin Reprod Med       Date:  2015-06-02       Impact factor: 1.303

8.  Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells.

Authors:  Johanny Tonos De Leon; Aki Iwai; Clementine Feau; Yenni Garcia; Heather A Balsiger; Cheryl L Storer; Raquel M Suro; Kristine M Garza; Sunmin Lee; Yeong Sang Kim; Yu Chen; Yang-Min Ning; Daniel L Riggs; Robert J Fletterick; R Kiplin Guy; Jane B Trepel; Leonard M Neckers; Marc B Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

9.  Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation.

Authors:  Juilee Rege; Yasuhiro Nakamura; Fumitoshi Satoh; Ryo Morimoto; Michael R Kennedy; Lawrence C Layman; Seijiro Honma; Hironobu Sasano; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

Review 10.  Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.

Authors:  Andrew K Hotchkiss; Cynthia V Rider; Chad R Blystone; Vickie S Wilson; Phillip C Hartig; Gerald T Ankley; Paul M Foster; Clark L Gray; L Earl Gray
Journal:  Toxicol Sci       Date:  2008-02-16       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.